Dr. Smitha C Saldanha

   MBBS, MD (General Medicine), DM (Medical Oncology), Fellowship in BMT

Book An Appointment

Home / Doctors / Dr. Smitha C Saldanha

Dr. Smitha C Saldanha


MBBS, MD (General Medicine), DM (Medical Oncology), Fellowship in BMT


Medical Oncology
Haematology and Bone Marrow Transplant


HCG Cancer Centre - K. R. Road, Bengaluru


8 Years

  • Dr. Smitha’s primary interest is in haemato oncology & bone marrow transplantation (BMT).  
  • She also has interest in treating paediatric tumours.
  • Her expertise lies mainly in treating breast cancer, leukemias, lymphomas, multiple myeloma, gastrointestinal cancers, genitourinary cancers, head & neck cancers and lung cancers.
  • Dr. Smitha attends over 5000 cases every year.
Training and Certifications
  • ESMO exam for medical oncologists from the European Society of Medical Oncology in 2017
  • Fellowship training in Bone Marrow Transplantation in 2019
  • NITTE Education Trust Award – Gold Medal and Highest marks in Community Medicine, RGUHS, 2003
  • NITTE Education Trust Award – Gold Medal and Highest marks in ENT, RGUHS, 2003.
  • ESMO ASIA 2015 ISMPO travel grant at ISMPOCON, Mumbai, Nov 2015.
  • Best Poster Award at the ISMPOCON, Mumbai, Nov 2015.
  • Pfizer grant for Research Hypothesis presentation at ISMPOCON Nov 2016.
  • RCC Perceptorship programme at Taiwan
  • ESMO Preceptorship on Metastatic Bladder and Kidney Cancer - Multidisciplinary management, standards of care, therapeutic targets and future perspectives, 19-20 September 2018, Singapore.
  • ESMO Preceptorship on Non-Small-Cell Lung Cancer - Standards of care, evolving paradigm and future perspectives, 21-22 November 2018, Singapore.
  • ESMO Preceptorship on Immuno-Oncology - From the essentials of tumour immunology to clinical application,26-27 November 2018, Singapore
  • Presentation at ESMO Congress 2019 at Spain
  • IASLC WCLC 2019 at Spain
  • Study on Awareness among School Children on the spread, symptoms, treatment and prevention of Malaria in an urban endemic area of South India. Karnataka Paediatric Journal, 24 (1), January-March 2010: p 4-6
  • A Study on the Awareness observed among Individuals living in Endemic Area on the Spread, Symptoms, Treatment and prevention of Malaria. Al Ameen J Med Sci 4 (1), January-March 2011: p 80-83
  • An Interesting Case Report on Cerebellar and Psychiatric Manifestations in Malaria. Journal of Clinical and Diagnostic Research, October 2011, 5 (5): 1104-6
  • Extermination of the Smallpox Virus – Light at the End of the Tunnel… or not – the Stalemate Continues. Annals of Community Health, 2014 Apr; 2 (2): 2-3.
  • Langerhans Cell Sarcoma – Review of Literature and a Rare Case Report . J Mol BiomarkDiagn2014; 5:181.
  • Plasmablastic lymphoma of bone in a human immunodeficiency virus positive child – A rare extra-oral presentation. Pediatric Infectious Disease, 2014;  6 (4), 142 – 144
  • Epigenetic therapy of cancer with histonedeacetylase inhibitors. Journal of Cancer Research and Therapeutics, 2014; 10 ( 3): 469-478
  • A study of comparison of prognostic models in peripheral T cell lymphoma in a tertiary care centre in South India. Annals of Oncology 26 (Supplement 9): ix85–ix92, 2015
  • The Efficacy, safety and cost benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: a pilot study from south India. Chemotherapy Research and Practice, vol. 2016, Article ID 3439707, 2016.
  • Hairy Cell Leukemia – Clinical Profile and treatment outcome from a tertiary regional cancer institute in South India. Clin Cancer InvestigJ, 2016; 5:141-5.
  • Breast cancer as second malignant neoplasm after acute myeloid leukemia: A rare occurence.Clin Cancer investig J, 2016; 333-5.
  • Gemcitabine – induced supraventricular tachycardia: A rare manifestation. Clin Cancer Investig J 2016; 5:200-2.
  • Clinicopathological profile of pure Neuroendocrineneoplasms of the Esophagus: A South Indian center experience. Journal of Oncology 2016.
  • Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India. Lung India?: Official Organ of Indian Chest Society. 2017;34(2):176-178.
  • Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India. South Asian Journal of Cancer, 2017. 6 (2); 72-74
  • Role Of Taxanes In Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center In South India. World Journal of Oncology, 2017. 8(4): 110-116.
  • Patterns and the Occurrence of KRAS Mutations in Metastatic Colorectal Cancers—a Study from Indian Regional Cancer Centre. Indian J SurgOncol (2017) 8: 511.
  • Role of prephase treatment prior to definitive chemotherapy in diffuse large B -cell lymphoma (DLBCL). Annals of Oncology 28 (Supplement 5), 2017: 361-61
  • Primary breast angiosarcoma - a single institution experience from a tertiary cancer center in South India. Breast Dis. 2017 Dec 28.
  • Clinical profile and outcomes of carcinoma anal canal: A single institution experience. Annals of Oncology (2017) 28 (suppl 10): x57-x76.
  • 290PExtranodal NK/T cell lymphoma- nasal type: Experience from an Indian regional cancer centre, November 2018Annals of Oncology 29(suppl_9),
  • Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma. Eur J Haematol. 2018; 100: 644– 648.
  • Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India, South Asian Journal of Cancer, 10.4103/sajc.sajc_52_18, 8, 1, (57), (2019).
  • Primary adrenal leiomyosarcoma: An extremely rare mesenchymal tumor, January 2019Indian journal of medical and paediatric oncology 40(4):559.
  • Induction Related Mortality in Acute Myeloid Leukemia: Multivariate Model of Predictive Score from the Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC), Blood, Nov 2019. 
  • EP1.14-32 Pattern of EGFR Mutations and Response to First Generation EGFR TKIs in Patients of Metastatic Lung Cancer at a Tertiary Care Centre in India, Journal of Thoracic Oncology, Oct 2019  
  • Clinico-epidemiological profile of Neuroendocrine tumors from a tertiary regional cancer institute in India – Accepted for publication in Indian Journal of Cancer

   Practices at

Other Doctors